Tango Therapeutics, Inc. (TNGX)
NASDAQ: TNGX · Real-Time Price · USD
20.98
-0.64 (-2.96%)
At close: May 1, 2026, 4:00 PM EDT
20.60
-0.38 (-1.81%)
After-hours: May 1, 2026, 7:54 PM EDT
Tango Therapeutics Market Cap
Tango Therapeutics has a market cap or net worth of $3.03 billion as of May 1, 2026. Its market cap has increased by 2,086.91% in one year.
Market Cap
3.03B
Enterprise Value
2.72B
1-Year Change
2,086.91%
Ranking
Category
Stock Price
$20.98
Market Cap Chart
Since April 20, 2021, Tango Therapeutics's market cap has increased from $156.31M to $3.03B, an increase of 1,836.07%. That is a compound annual growth rate of 80.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 1, 2026 | 3.03B | 153.61% |
| Dec 31, 2025 | 1.19B | 259.49% |
| Dec 31, 2024 | 331.92M | -67.13% |
| Dec 29, 2023 | 1.01B | 57.94% |
| Dec 30, 2022 | 639.29M | -33.25% |
| Dec 31, 2021 | 957.76M | 512.74% |
| Apr 20, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NewAmsterdam Pharma Company | 3.27B |
| Kailera Therapeutics | 3.26B |
| Arcus Biosciences | 3.23B |
| Alumis | 3.20B |
| Erasca | 3.12B |
| Beam Therapeutics | 3.08B |
| Structure Therapeutics | 3.00B |
| Arcutis Biotherapeutics | 2.92B |